ArticlePharmacoEconomics2018

Sacubitril/Valsartan (LCZ696): A Novel Treatment for Heart Failure and its Estimated Cost Effectiveness, Budget Impact, and Disease Burden Reduction in Germany.

Afschin Gandjour et al.PubMed ↗Publisher ↗

No numbers read from the abstract.